16 studies found for:    " October 31, 2007":" November 30, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" October 31, 2007":" November 30, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (16 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples
Conditions: HIV-1 Infections;   HIV Infections
Interventions: Drug: Tenofovir Disoproxil Fumarate (TDF);   Drug: Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF);   Drug: Placebo
2 Completed Incidence and Severity of Neuropsychiatric Adverse Events of Efavirenz Given as a Stepped Dosage vs. the Usual Dosage
Conditions: HIV-1 Infection;   HIV Infection
Intervention: Drug: Efavirenz
3 Recruiting Lymphocyte Infusions for the Treatment of HIV-Infected Patients Failing Anti-HIV Therapy
Condition: HIV Infections
Intervention: Drug: Cell Transfer
4 Completed Effect of HIV/STD Risk Reduction Program on South African Adolescents
Conditions: HIV Infections;   Sexually Transmitted Disease
Interventions: Behavioral: HIV/STD Risk-Reduction;   Behavioral: Health Promotion
5 Completed Nutrition Intervention in Drug Naive HIV-infected Kenyan Women and Their Children
Condition: HIV Infections
Interventions: Dietary Supplement: Meat Biscuit;   Dietary Supplement: Soy Biscuit;   Dietary Supplement: Wheat Biscuit
6 Enrolling by invitation Utilization of HIV Clinical Services in Rural India
Conditions: HIV Infections;   Sexually Transmitted Infections
Intervention: Behavioral: HIV Testing and Care Services
7 Completed CDC HIV Testing Guidelines: Unresolved Ethical Concerns
Condition: HIV Infections
Intervention: Other: CDC HIV testing recommendations
8 Completed Impact of MK-0518 (Raltegravir) Intensification on HIV-1 Viral Latency in Patients With Previous Complete Viral Suppression
Condition: HIV Infections
Intervention: Drug: MK-0518 400mg twice a day
9 Unknown  Effects of Antihypertensive Treatment in HIV Infected Patients: Candesartan Versus Lercanidipine
Conditions: HIV Infections;   Hypertension
Interventions: Drug: candesartan;   Drug: lercanidipine
10 Completed Pharmacokinetic Study of the Vaginal Microbicide Agent 1% Tenofovir Gel
Condition: HIV Infections
Intervention: Drug: Tenofovir gel
11 Unknown  Raltegravir Added to Stable HAART in HIV-1 Infected Subjects With Viral Suppression and Low CD4 Recovery
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Placebo
12 Completed Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected Patients
Conditions: Hepatitis C, Chronic;   HIV Infections
Interventions: Drug: Pegylated interferon alfa-2a and Ribavirin;   Drug: Pegylated interferon alfa 2a and Ribavirin
13 Completed Immune Response to Toll-Like Receptor 9-Agonist Adjuvanted Pneumococcal Vaccination in HIV Infected Adults
Condition: HIV Infections
Interventions: Biological: Pneumococcal vaccines + CPG 7909;   Biological: Pneumococcal vaccines
14 Completed
Has Results
VERxVE Study on Efficacy and Safety of Nevirapine XR in Comparison to Nevirapine IR With Truvada in Naive HIV+ Patients
Condition: HIV Infections
Interventions: Drug: nevirapine IR;   Drug: nevirapine XR
15 Completed Pilot, Opened, Randomized Clinical Trial to Assess the Efficacy of Duloxetine in the Treatment of Fibromialgy in Patients With Infection by HIV 1+
Conditions: Fibromyalgia;   HIV-1 Infection
Intervention: Drug: Duloxetine 60 mg, QD
16 Completed Evaluation and Monitoring of Patients With HIV Infectionn
Condition: HIV
Intervention:

Indicates status has not been verified in more than two years